- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: HR /HER2- advanced/metastatic breast cancer
Total 99232 results
-
RemeGen Co., Ltd.Completed
-
Universitair Ziekenhuis BrusselKom Op Tegen Kanker; Agentschap voor Innovatie door Wetenschap en Technologie...RecruitingGastric Cancer | Colorectal Cancer | Prostate Cancer | Non Small Cell Lung Cancer | Cholangiocarcinoma | Endometrial Cancer | Urothelial Carcinoma | Biliary Tract Cancer | Locally Advanced Breast Cancer | Cancer of Pancreas | Uterine Cancer | Salivary Gland Cancer | Metastatic Breast Carcinoma | Solid Tumor With Intermediate...Belgium
-
Anne Arundel Health System Research InstituteGenentech, Inc.Unknown
-
Zhi YangWithdrawnGlioma | Breast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Lung CancerChina
-
Peking Union Medical College HospitalCompletedBreast CancerChina
-
Karolinska University HospitalRecruitingBreast Cancer | Esophageal Neoplasms | HER2-positive Gastric Cancer | Gastric Neoplasms MalignantSweden
-
PrecirixCompleted
-
Peking University First HospitalNot yet recruiting
-
Xijing HospitalNot yet recruitingHER2-positive Breast Cancer and Gastric Cancer
-
Alphamab (Australia) Co Pty Ltd.RecruitingAdvanced Solid Tumors | Metastatic Solid TumorsAustralia
-
Beijing 302 HospitalRecruiting
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruiting
-
Dorte NielsenTerminated
-
Pieris Pharmaceuticals, Inc.CompletedHER2-positive Breast Cancer | HER2-positive Gastric Cancer | HER2-positive Bladder Cancer | HER2-positive Solid TumorUnited States
-
University of Maryland, BaltimoreWithdrawnBreast Cancer With Brain MetastasisUnited States
-
Bavarian NordicCompletedBreast CancerUnited States
-
Mersana TherapeuticsRecruitingHER2-positive Breast Cancer | HER2-positive Gastric Cancer | HER2-positive Non-Small Cell Lung Cancer | HER2-positive Colorectal Cancer | HER2-positive Tumors | HER2 Low Breast CancerUnited States
-
Peking Union Medical College HospitalCompleted
-
First People's Hospital of HangzhouMacera therapeuticsNot yet recruiting
-
Thomas HatschekActive, not recruitingEarly-Stage Breast Carcinoma | HER-2 Positive Breast CancerSweden
-
Hunan Cancer HospitalCompletedBreast Neoplasms | HER2-positive Breast CancerChina
-
Zhejiang Cancer HospitalCompletedBreast Cancer | HER2 | Preoperative Systemic Treatment
-
Beijing 302 HospitalRecruiting
-
Bavarian NordicCompletedBreast CancerUnited States
-
Enliven TherapeuticsRecruitingHER2-positive Metastatic Breast Cancer | HER2 Gene Mutation | HER2 Mutant Non-small Cell Lung Cancer | HER2 AmplificationUnited States, Spain, Korea, Republic of, Taiwan, Italy, Australia, France
-
Iksuda Therapeutics Ltd.RecruitingBreast Cancer | Gastric Cancer | Gastroesophageal-junction CancerAustralia
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingMetastatic Breast CancerItaly
-
University of VirginiaTerminatedBreast Cancer Female | Leptomeningeal MetastasesUnited States
-
Jules Bordet InstituteCompletedBreast Neoplasms | Secondary | HER2 Positive Carcinoma of BreastBelgium
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...CompletedHER2 Positive MalignanciesUnited States
-
Sichuan UniversityRecruitingPleural Effusion, Malignant | Peritoneal Carcinoma MetastaticChina
-
G1 Therapeutics, Inc.Active, not recruitingBreast Cancer | Breast Neoplasm | Carcinoma, Ductal, BreastUnited Kingdom, Bulgaria, Georgia, Moldova, Republic of
-
Shanghai General Hospital, Shanghai Jiao Tong University...NanoMab Technology (UK) LimitedRecruitingBreast Cancer | RadiotoxicityChina
-
Peking University Cancer Hospital & InstituteRecruitingHER2 Positive or Suspicious Positive TumorsChina
-
Daiichi SankyoCompletedHER2-negative Breast Cancer | HER2-low Breast Cancer | Hormone-receptor-positive Breast CancerUnited States
-
Bristol-Myers SquibbCompletedSolid Tumors That Overexpress HER2 (HER2 Positive)United States, Canada
-
H. Kim LyerlySusan G. Komen Breast Cancer FoundationCompleted
-
First Affiliated Hospital of Zhejiang UniversityNot yet recruiting
-
QuantumLeap Healthcare CollaborativeRecruitingSolid Tumor | Metastatic Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Solid Tumor, Adult | Solid Carcinoma | HER2-positive Metastatic Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast Cancer | Estrogen Receptor Positive... and other conditionsUnited States
-
GeneQuantum Healthcare (Suzhou) Co., Ltd.RecruitingHER2-positive Breast Cancer | HER2-positive Biliary Tract Cancer | HER2-Positive Salivary Gland Carcinomas | HER2-Positive Advanced Solid TumorChina, Australia, United States
-
Providence Health & ServicesActive, not recruitingBreast CancerUnited States
-
Jonsson Comprehensive Cancer CenterEli Lilly and Company; Genentech, Inc.RecruitingMetastatic Lung Non-Small Cell Carcinoma | Refractory Lung Non-Small Cell Carcinoma | Stage IV Lung Cancer American Joint Committee on Cancer (AJCC) v8 | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8United States
-
Dana-Farber Cancer InstituteJohns Hopkins University; National Cancer Institute (NCI); Gateway for Cancer... and other collaboratorsRecruitingBreast Cancer | Metastatic Breast Cancer | HER2-positive Breast CancerUnited States
-
ABSCINT NV/SANot yet recruiting
-
Abramson Cancer Center at Penn MedicineActive, not recruitingAdvanced Breast Cancer | Metastatic Breast Cancer | BRCA1 Mutation | BRCA2 Mutation | Locally Advanced Breast CancerUnited States
-
Baylor College of MedicineThe Methodist Hospital Research InstituteRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Esophageal Cancer | Pancreatic Adenocarcinoma | Lung Cancer | Solid Tumor | Bladder Cancer | Head and Neck Squamous Cell Carcinoma | Cancer of the Salivary GlandUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedHER2-positive Carcinoma | HER2-positive Primary MalignancyUnited States
-
Novartis PharmaceuticalsCompletedNON-breast HER2+ MalignanciesUnited States, Italy, Korea, Republic of, Japan
-
Orum Therapeutics USA, Inc.RecruitingHER2-positive Breast Cancer | HER-2 Gene Amplification | HER2 Gene Mutation | HER-2 Protein OverexpressionUnited States
-
Masonic Cancer Center, University of MinnesotaActive, not recruitingTriple Negative Breast Cancer | HER2-positive Breast Cancer | TN ER-/PR-/HER2- Breast Cancer | ERany/PRany/HER2+ Breast CancerUnited States